Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

36. Taher K W, Johnson P N, Miller J L, Neely S, Gupta N. Efficacy and Safety of Prolonged Magnesium Sulfate Infusions in Children With Refractory Status Asthmaticus. Frontiers in pediatrics. 2022; 10 : 860921

37. Bobo K S, Cober M P, Eiland L S, Heigham M, King M, Johnson P N, Miller J L, Sierra C M. Correction to: Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022; 79 : 823

38. Johnson P N. ICU Psychosis and Delirium. American College of Clinical PHarmacy. 2022 : 101-124

39. Johnson P N, Drury A S, Gupta N. Continuous Magnesium Sulfate Infusions for Status Asthmaticus in Children: A Systematic Review. Frontiers in pediatrics. 2022; 10 : 853574

40. Besunder J B, Betters K A, Johnson P N, Srinivasan V, Stormorken A, Farrington E, Golianu B, Godshall A J, Acinelli L, Almgren C, Bailey C H, Boyd J M, Cisco M J, Damian M, deAlmeida M L, Fehr J, Fenton K E, Gilliland F, Howell J, Ruggles C A, Simone S, Su F, Sullivan J E, Tegtmeyer K, Traube C, Williams S, Berkenbosch J W. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2022; 23 : e74-e110

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

26. Pediatric Pharmacy Advocacy Group. Original Research Award. Date: 2014.


27. Pediatric Pharmacy Advocacy Group. Presidential Citation. Date: 2013.


28. American College of Clinical Pharmacy. Volunteer Member Recognition Nominee. Date: 2013.


29. Oklahoma Society of Health-System Pharmacists. Oustanding Service Award. Date: 2013.


30. University of Oklahoma College of Pharmacy. Rho-Chi--Inductee. Date: 2013.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results